Cargando…

Could DOAC Be a Better Choice Than Warfarin in Low Compliance Patients with Fontan Procedure?

Background and Objectives: After the Fontan procedure, thromboembolic events need to be prevented. We present a young patient with a history of Fontan procedure and poor adherence to warfarin who developed systemic thromboembolism. He was changed to maintenance dabigatran, which is one of the availa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jisoo, Hong, Bo-Young, Kim, Joon-Sung, Park, Jung-Geun, Jung, Jiyoon, Lim, Seong-Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151865/ https://www.ncbi.nlm.nih.gov/pubmed/34068569 http://dx.doi.org/10.3390/medicina57050465

Ejemplares similares

Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOACs on Several Thrombophilia Screening Tests
por: Favresse, Julien, et al.
Publicado: (2018)

DOACs for VTE in patients with brain cancer and brain metastases: choices, choices, choices
por: Buka, Richard J., et al.
Publicado: (2022)

Physiological Fontan Procedure
por: Corno, Antonio F., et al.
Publicado: (2019)

Effectiveness and Safety of DOACs vs. Warfarin in Patients With Atrial Fibrillation and Frailty: A Systematic Review and Meta-Analysis
por: Zeng, Shan, et al.
Publicado: (2022)

The Fontan procedure is no longer the last operation
por: Venna, Alyssia, et al.
Publicado: (2022)

Direct oral anticoagulants versus warfarin: is new always better than the old?
por: Burn, John, et al.
Publicado: (2018)

Uninterrupted DOACs Approach for Catheter Ablation of Atrial Fibrillation: Do DOACs Levels Matter?
por: Hardy, Michael, et al.
Publicado: (2022)

DOAC in COVID-19: Yes or No?
por: Schutgens, Roger E.
Publicado: (2020)

Adverse Events of DOACs in Children
por: Bosch, Alessandra, et al.
Publicado: (2022)

DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in Circulation
por: Margetić, Sandra, et al.
Publicado: (2022)

Hypervascular hepatic masses in a patient who underwent the Fontan procedure
por: Kang, Min Kyu, et al.
Publicado: (2022)

Correction: Direct oral anticoagulants versus warfarin: is new always better than the old?
Publicado: (2018)

Reflections on Five Decades of the Fontan Kreutzer Procedure
por: Kreutzer, Christián, et al.
Publicado: (2013)

Percutaneous coronary intervention following Fontan procedure
por: Subahi, Ahmed, et al.
Publicado: (2020)

Pregnancy Outcomes in Women after the Fontan Procedure
por: Bartczak-Rutkowska, Agnieszka, et al.
Publicado: (2023)

Cryptochrome magnetoreception: four tryptophans could be better than three
por: Wong, Siu Ying, et al.
Publicado: (2021)

Is suvorexant a better choice than alternative hypnotics?
por: Kripke, Daniel F.
Publicado: (2015)

The Effect of Direct Oral Anticoagulant Therapy (DOACs) on oral surgical procedures: a systematic review
por: Darwish, Ghassan
Publicado: (2023)

DOACs – advances and limitations in real world
por: Lee, Lai Heng
Publicado: (2016)

DOAC drug interactions management resource
por: Chadha, Ayush, et al.
Publicado: (2022)

Warfarin: better the devil you know
por: Blockman, Marc
Publicado: (2017)

Commentary: Innominate turndown—a better insurance for the Fontan circulation?
por: Sinha, Pranava
Publicado: (2021)

Arterial stiffness in adult patients after Fontan procedure
por: Tomkiewicz-Pajak, Lidia, et al.
Publicado: (2014)

Association of Direct Oral Anticoagulants (DOACs) and Warfarin With Haemorrhagic Risk by Applying Correspondence Analysis to Data From the Italian Pharmacovigilance Database – A Case Study
por: Gaio, Mario, et al.
Publicado: (2021)

Management and 1-Year Outcome in Elderly Patients with Hip Fracture Surgery Receiving Anticoagulation (Warfarin or DOAc) or P2Y12 Antiplatelet Agents
por: Rostagno, Carlo, et al.
Publicado: (2023)

Peri-Procedural Management of Direct-Acting Oral Anticoagulants (DOACs) in Transcatheter Miniaturized Leadless Pacemaker Implantation
por: Regoli, François Diederik, et al.
Publicado: (2023)

Compliance with Primary Malaria Chemoprophylaxis: Is Weekly Prophylaxis Better Than Daily Prophylaxis?
por: Rodrigo, Chaturaka, et al.
Publicado: (2020)

Bariatric Surgery can Lower the Efficacy of DOACs
por: Bitar, Zouheir Ibrahim, et al.
Publicado: (2020)

Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)
por: Dunois, Claire
Publicado: (2021)

Resistance over compliance describes right ventricular afterload better than resistance-compliance time: a friendly amendment
por: Thenappan, Thenappan, et al.
Publicado: (2017)

Renal abscess after the Fontan procedure: a case report
por: Mehrotra, Anurag, et al.
Publicado: (2011)

Anaesthesia for a minor procedure in a patient with fontan physiology
por: D’souza, Shirley, et al.
Publicado: (2012)

Imaging insights from the bifurcated Y-graft Fontan procedure
por: Slesnick, Tim, et al.
Publicado: (2016)

Diastolic Dysfunction With Preserved Ejection Fraction After the Fontan Procedure
por: Chowdhury, Shahryar M., et al.
Publicado: (2022)

Body Mass Index Trajectory and Outcome Post Fontan Procedure
por: Payne, Emma, et al.
Publicado: (2022)

Evaluation of the DOAC-Stop Procedure by LC-MS/MS Assays for Determining the Residual Activity of Dabigatran, Rivaroxaban, and Apixaban
por: Slavik, L., et al.
Publicado: (2019)

Characterization of baseline hemodynamics after the Fontan procedure: a retrospective cohort study on the comparison of 4D Flow MRI and computational fluid dynamics
por: Lee, Gyu-Han, et al.
Publicado: (2023)

The Correlation between the Change in Thoracic Fluid Content and the Change in Patient Body Weight in Fontan Procedure
por: Yoon, Tae-Gyoon, et al.
Publicado: (2018)

Abdominal imaging findings in adult patients with Fontan circulation
por: Kim, Tae-Hyung, et al.
Publicado: (2018)

New Direct Oral Anticoagulants (DOAC) and Their Use Today
por: Schwarb, Heike, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d9f4p0ekpj85geeglek18h1kh5